Novel non-nucleotidic STING agonists for cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel non-nucleotidic STING agonists for cancer immunotherapy

Published:2018-12 Issue:24 Volume:10 Page:2767-2769
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Medicinal Chemistry

Author:

Berger Gilles¹,Lawler Sean E²

Affiliation:

1. Faculty of Pharmacy, Microbiology, Bioorganic & Macromolecular Chemistry, Université libre de Bruxelles, Bd du Triomphe, 1050 Brussels, Belgium

2. Department of Neurosurgery, Harvey Cushing Neuro-Oncology Laboratories, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.future-science.com/doi/pdf/10.4155/fmc-2018-0367

Reference20 articles.

1. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling

2. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer

3. STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia

4. Clinical Trials Database: NCT03172936. https://clinicaltrials.gov/ct2/show/NCT03172936.

5. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of new benzofuran derivatives as STING agonists with broad-spectrum antiviral activity;Virus Research;2024-09

2. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy;Acta Biomaterialia;2024-03

3. Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives;Materials Today Bio;2023-12

4. Unlocking STING as a Therapeutic Antiviral Strategy;International Journal of Molecular Sciences;2023-04-18

5. Which treatment after first line therapy in NSCLC patients without genetic alterations in the era of immunotherapy?;Critical Reviews in Oncology/Hematology;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3